408 related articles for article (PubMed ID: 19837463)
1. Glutamate-based antidepressants: 20 years on.
Skolnick P; Popik P; Trullas R
Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
[TBL] [Abstract][Full Text] [Related]
2. The role of glutamate on the action of antidepressants.
Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
[TBL] [Abstract][Full Text] [Related]
3. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
Hashimoto K
J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
[No Abstract] [Full Text] [Related]
4. NMDA antagonists under investigation for the treatment of major depressive disorder.
Pochwat B; Pałucha-Poniewiera A; Szewczyk B; Pilc A; Nowak G
Expert Opin Investig Drugs; 2014 Sep; 23(9):1181-92. PubMed ID: 24818801
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan as a potential rapid-acting antidepressant.
Lauterbach EC
Med Hypotheses; 2011 May; 76(5):717-9. PubMed ID: 21367535
[TBL] [Abstract][Full Text] [Related]
6. The involvement of glutamate in the pathophysiology of depression.
Palucha A; Pilc A
Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
[TBL] [Abstract][Full Text] [Related]
7. Glutamate-based antidepressants: preclinical psychopharmacology.
Pilc A; Wierońska JM; Skolnick P
Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
[TBL] [Abstract][Full Text] [Related]
8. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
Krystal JH
Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
[No Abstract] [Full Text] [Related]
10. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
Pałucha A; Pilc A
Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
[TBL] [Abstract][Full Text] [Related]
11. Targeting glutamate signalling in depression: progress and prospects.
Murrough JW; Abdallah CG; Mathew SJ
Nat Rev Drug Discov; 2017 Jul; 16(7):472-486. PubMed ID: 28303025
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
Heresco-Levy U; Javitt DC; Gelfin Y; Gorelik E; Bar M; Blanaru M; Kremer I
J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of glutamate in the pathophysiology of major depressive disorder.
Hashimoto K
Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. CP-101606 Pfizer Inc.
Chazot PL
Curr Opin Investig Drugs; 2000 Nov; 1(3):370-4. PubMed ID: 11249721
[TBL] [Abstract][Full Text] [Related]
16. How does ketamine elicit a rapid antidepressant response?
Kavalali ET; Monteggia LM
Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
[TBL] [Abstract][Full Text] [Related]
17. [Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].
Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł
Psychiatr Pol; 2012; 46(2):283-94. PubMed ID: 23214398
[TBL] [Abstract][Full Text] [Related]
18. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
[TBL] [Abstract][Full Text] [Related]
19. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
Skolnick P; Layer RT; Popik P; Nowak G; Paul IA; Trullas R
Pharmacopsychiatry; 1996 Jan; 29(1):23-6. PubMed ID: 8852530
[TBL] [Abstract][Full Text] [Related]
20. 5-HT7 receptor antagonists as a new class of antidepressants.
Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
